We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$60.8B
1-Year Est. Return
42.06%
This Fund
S&P 500
This Quarter
Est. Return
+25.48%
1 Year Est. Return
+42.06%
3 Year Est. Return
+131.09%
5 Year Est. Return
+176.11%
10 Year Est. Return
–
AUM
$60.8B
AUM Growth
+$7.15B
(+13%)
Cap. Flow
-$361M
Cap. Flow
% of AUM
-0.59%
Top 10 Holdings %
Top 10 Hldgs %
35.18%
Holding
1,761
New
53
Increased
521
Reduced
753
Closed
37
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$294M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$211M |
| 3 |
Citigroup
C
|
+$134M |
| 4 |
Lam Research
LRCX
|
+$93.2M |
| 5 |
Merck
MRK
|
+$88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$228M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$185M |
| 3 |
Knight Transportation
KNX
|
+$177M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$144M |
| 5 |
LyondellBasell Industries
LYB
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.4% |
| 2 | Financials | 11.52% |
| 3 | Healthcare | 11.15% |
| 4 | Communication Services | 9.3% |
| 5 | Consumer Discretionary | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
West Pharmaceutical
WST
$23.9B
| $10.6M | 0.02% |
29,576
+1,167
| +4% | +$357K |
|
427
Energy Transfer Partners
ET
$74B
| $10.6M | 0.02% |
555,230
| – | – |
|
428
HealthEquity
HQY
$7.95B
| $10.6M | 0.02% |
117,281
-17,096
| -13% | -$1.45M |
|
|
EXE
429
Expand Energy Corp
EXE
$22.7B
| $10.6M | 0.02% |
116,070
+15,312
| +15% | +$1.45M |
|
430
Ameren
AEE
$29.5B
| $10.4M | 0.02% |
92,040
+5,731
| +7% | +$633K |
|
431
Leidos
LDOS
$16.7B
| $10.3M | 0.02% |
100,316
+67,140
| +202% | +$8.92M |
|
|
BCAX
432
Bicara Therapeutics
BCAX
$1.53B
| $10.2M | 0.02% |
342,211
-59,233
| -15% | -$1.32M |
|
433
Royal Bank of Canada
RY
$292B
| $10.2M | 0.02% |
49,081
| – | – |
|
434
DTE Energy
DTE
$28.3B
| $10.1M | 0.02% |
66,465
-24,258
| -27% | -$3.54M |
|
435
AstraZeneca
AZN
$252B
| $10.1M | 0.02% |
54,111
+350
| +0.7% | +$65.8K |
|
436
Vulcan Materials
VMC
$34B
| $10.1M | 0.02% |
34,323
-10,212
| -23% | -$2.93M |
|
437
Construction Partners
ROAD
$5.94B
| $10.1M | 0.02% |
84,778
-442
| -0.5% | -$52.4K |
|
438
Cirrus Logic
CRUS
$5.67B
| $10.1M | 0.02% |
67,739
+35,543
| +110% | +$5.82M |
|
439
IDEAYA Biosciences
IDYA
$3.85B
| $9.96M | 0.02% |
267,182
-632,322
| -70% | -$19.4M |
|
440
Paycom
PAYC
$10.4B
| $9.95M | 0.02% |
79,165
+68,078
| +614% | +$8.88M |
|
441
MACOM Technology Solutions
MTSI
$20.5B
| $9.89M | 0.02% |
25,991
+22,435
| +631% | +$7.44M |
|
442
BWX Technologies
BWXT
$14.4B
| $9.79M | 0.02% |
50,273
-151,864
| -75% | -$31.6M |
|
443
Darling Ingredients
DAR
$10.3B
| $9.72M | 0.02% |
177,901
+28,491
| +19% | +$1.7M |
|
444
Ultragenyx Pharmaceutical
RARE
$1.51B
| $9.71M | 0.02% |
290,818
+284,097
| +4,227% | +$7.06M |
|
445
FirstEnergy
FE
$27.1B
| $9.66M | 0.02% |
203,095
-9,332
| -4% | -$443K |
|
446
Repligen
RGEN
$9.46B
| $9.51M | 0.02% |
69,687
-6,333
| -8% | -$778K |
|
447
DexCom
DXCM
$33.2B
| $9.49M | 0.02% |
140,932
-221,780
| -61% | -$14.8M |
|
448
GoDaddy
GDDY
$12.8B
| $9.47M | 0.02% |
111,552
+69,041
| +162% | +$5.82M |
|
449
Northern Trust
NTRS
$34.1B
| $9.45M | 0.02% |
54,355
-4,508
| -8% | -$743K |
|
450
Atmos Energy
ATO
$28.3B
| $9.44M | 0.02% |
54,784
+10,535
| +24% | +$1.89M |
|
Similar funds
Ensign Peak Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Ensign Peak Advisors held 1,761 positions worth $60.8B, up 13% from $53.7B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Ensign Peak Advisors's Q2 2026 filing shows 53 new, 521 increased, 753 reduced and 37 closed positions. Its largest new stake was Honeywell Aerospace: 319,358 shares worth $70.6M. The largest sale was NVIDIA, an estimated $228M.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 31% a quarter earlier, followed by Financials and Healthcare.
- Ensign Peak Advisors's largest Q2 2026 buy was Honeywell Aerospace: 319,358 shares worth $70.6M.
- Ensign Peak Advisors added most to Advanced Micro Devices in Q2 2026, an estimated $294M increase.
- Ensign Peak Advisors's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $228M.
- Ensign Peak Advisors fully exited State Street SPDR S&P 500 ETF Trust in Q2 2026, selling an estimated $144M.
- Ensign Peak Advisors's ten largest holdings make up 35% of its $60.8B portfolio in Q2 2026.
- Ensign Peak Advisors opened 53 new positions and closed 37 in Q2 2026.
- Ensign Peak Advisors's portfolio value rose 13% quarter-over-quarter to $60.8B.
Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.